Reciprocal regulation of IL-6 and IL-10 balance by HGF via recruitment of heme oxygenase-1 in macrophages for attenuation of liver injury in a mouse model of endotoxemia

International Journal of Molecular Medicine

Volumn 24, Issue 2, 2009, Pages 161-170

  Kamimoto, Miyuki ^a   Mizuno, Shinya ^a   Nakamura, Toshikazu ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Acute liver injury; Growth factor therapy; Host defense system; Hypercytokinemia; Systemic immune response syndrome

Indexed keywords

HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTOXEMIA; FEMALE; IN VIVO STUDY; LIVER INJURY; LIVER PROTECTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ACUTE DISEASE; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER; LIVER DISEASE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; BLOTTING, WESTERN; CELL LINE; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; MACROPHAGES; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 70349311526     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000219     Document Type: Article

References (50)

1. Matthay MA: Severe sepsis: a new treatment with both anticoagulant and anti-inflammatory properties. N Engl J Med 344: 759-762, 2001.
2. Antoniades CG, Berry PA, Wendon JA and Vergani D: The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 49: 845-861, 2008.
3. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J and Williams R: The systemic inflammatory response syndrome in acute liver failure. Hepatology 32: 734-739, 2000.
4. Van der Poll T and van Deventer SJ: Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 13: 413-426, 1999.
5. Oberholzer A, Oberholzer C, Moldawer LL, Kumar A and Creery WD: The therapeutic potential of interleukin-10 in infection and inflammation. Arch Immunol Ther Exp 48: 529-538, 2000.
6. Ryter SW, Alam J and Choi AMK: Heme oxygenase-1/carbon monoxide: From basic science to therapeutic implications. Physiol Rev 86: 583-650, 2006.
7. Farombi EO and Surh YJ: Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 39: 479-491, 2006.
8. Kawashima A, Oda Y, Yachie A, Koizumi S and Nakanishi I: Heme oxygenase-1 deficiency: The first autopsy case. Hum Pathol 33: 125-130, 2002.
9. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA and Agarwal A: Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 165: 1045-1053, 2004.
10. Nakamura T, Nawa K and Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122: 1450-1459, 1984.
11. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K and Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
12. Funakoshi H and Nakamura T: Hepatocyte growth factor: from diagnosis to clinical application. Clin Chem Acta 327: 1-23, 2003.
13. Birchmeier C and Gherardi E: Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8: 404-410, 1998.
14. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K and Nakamura T: Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and for potent anti-hepatitis action in vivo. Hepatology 16: 1227-1235, 1992.
15. Mizuno S and Nakamura T: Hepatocyte growth factor: A regenerative drug for acute hepatitis and liver cirrhosis. Regener Med 2: 161-170, 2007.
16. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y and Nakamura T: Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244: 683-690, 1998.
17. Huh CG, Factor VM, Sánchez A, Uchida K, Conner EA and Thorgeirsson SS: Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 101: 4477-4482, 2004.
18. Li Z, Mizuno S and Nakamura T: Anti-necrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases. Am J Physiol Gastrointest Liver Physiol 292: G639-G646, 2007.
19. Sekine K, Fujishima S and Aikawa N: Plasma hepatocyte growth factor is increased in early-phase sepsis. J Infect Chemother 10: 110-114, 2004.
20. Galimi F, Cottone E, Vigna E, Arena N, Boccaccio C, Giordano S, Naldini L and Comoglio PM: Hepatocyte growth factor is a regulator of monocyte-macrophage function. J Immunol 166: 1241-1247, 2001.
21. Muftuoglu MA, Aktekin A, Ozdemir NC and Saglam A: Liver injury in sepsis and abdominal compartment syndrome in rats. Surg Today 36: 519-524, 2006.
22. Hsu HY, Chu LC, Hua KF and Chao LK: Heme oxygenase-1 mediates the anti-inflammatory effect of Curcumin within LPS-stimulated human monocytes. J Cell Physiol 215: 603-612, 2008.
23. Tajima H, Higuchi O, Mizuno K and Nakamura T: Tissue distribution of hepatocyte growth factor receptor and its exclusive down-regulation in a regenerating organ after injury. J Biochem 111: 401-406, 1992.
24. Mizuno S and Nakamura T: Hepatocyte growth factor: Physiological and therapeutic ligand to attenuate diabetic nephropathy. In: Diabetic Kidney. Mogensen CE and Cortes P (eds). Humana Press, Totawa, NJ, pp225-253, 2006.
25. Hattori N, Mizuno S, Yoshida Y, Chin K, Mishima M, Sisson TH, Simon RH, Nakamura T and Miyake M: The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. Am J Pathol 164: 1091-1098, 2004.
26. Clark IA, Awburn MM, Harper CG, Liomba NG and Molyneux ME: Induction of HO-1 in tissue macrophages and monocytes in fatal falciparum malaria and sepsis. Malar J 2: 41-53, 2003.
27. Reeve VE and Tyrrell RM: Heme oxygenase induction mediates the photoimmuno-protective activity of UVA radiation in the mouse. Proc Natl Acad Sci USA 96: 9317-9321, 1999.
28. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD and Jiang F: Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 50: 636-642, 2007.
29. Kosai K, Matsumoto K, Funakoshi H and Nakamura T: Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 30: 151-159, 1999.
30. Sass G, Seyfried S, Soares MP, Yamashita K, Kaczmarek E, Neuhuber WL and Tiegs G: Cooperative effect of biliverdin and carbon monoxide on survival of mice in immune-mediated liver injury. Hepatology 40: 1128-1135, 2004.
31. Ke B, Buelow R, Shen XD, Melinek J, Amersi F, Gao F, Ritter T, Volk HD, Busuttil RW and Kupiec-Weglinski JW: Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 13: 1189-1199, 2002.
32. Wang X, DeFrances MC, Dai Y, Pediaditakis P, Johnson C, Bell A, Michalopoulos GK and Zarnegar R: A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell 9: 411-421, 2002.
33. Lordnejad MR, Schliess F, Wettstein M and Häussinger D: Modulation of the heme oxygenase HO-1 expression by hyperosmolarity and betaine in primary rat hepatocytes. Arch Biochem Biophys 388: 285-292, 2001.
34. 2-induced mesangial cell apoptosis through induction of heme oxygenase-1. Nephron Physiol 101: 92-98, 2005.
35. Zhong J, Deaciuc IV, Burikhanov R and de Villiers WJ: Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice. Biochim Biophys Acta 1762: 468-477, 2006.
36. Chauveau C, Rémy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, Tesson L, Brion R, Beriou G, Gregoire M, Josien R, Cuturi MC and Anegon I: Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106: 1694-1702, 2005.
37. Xia ZW, Xu LQ, Zhong WW, Wei JJ, Li NL, Shao J, Li YZ, Yu SC and Zhang ZL: Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor-beta1. Am J Pathol 171: 1904-1914, 2007.
38. Futamatsu H, Suzuki J, Mizuno S, Koga N, Adachi S, Kosuge H, Maejima Y, Hirao K, Nakamura T and Isobe M: Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res 96: 823-830, 2005.
39. Okunishi K, Dohi M, Fujio K, Nakagome K, Tabata Y, Okasora T, Seki M, Shibuya M, Imamura M, Harada H, Tanaka R and Yamamoto K: Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol 179: 5504-5513, 2007.
40. Yamaura K, Ito K, Tsukioka K, Wada Y, Makiuchi A, Sakaguchi M, Akashima T, Fujimori M, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Suzuki J, Amano J and Isobe M: Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 110: 1650-1657, 2004.
41. Rutella S, Bonanno G, Procoli A, Mariotti A, de Ritis DG, Curti A, Danese S, Pessina G, Pandolfi S, Natoni F, Di Febo A, Scambia G, Manfredini R, Salati S, Ferrari S, Pierelli L, Leone G and Lemoli RM: Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12 low/neg accessory cells with dendritic-cell features. Blood 108: 218-227, 2006.
42. Van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H and Buller HR: Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179: 1253-1259, 1994.
43. Azuma H, Takahara S, Matsumoto K, Ichimaru N, Wang JD, Moriyama T, Waaga AM, Kitamura M, Otsuki Y, Okuyama A, Katsuoka Y, Chandraker A, Sayegh MH and Nakamura T: Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 12: 1280-1292, 2001.
44. Seto S, Kaido T, Yamaoka S, Yoshikawa A, Arii S, Nakamura T, Niwano M and Imamura M: Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats. J Surg Res 80: 194-199, 1998.
45. Morita M, Watanabe Y and Akaike T: Protective effect of hepatocyte growth factor on interferon-γ-induced cytotoxicity in mouse hepatocytes. Hepatology 21: 1585-1593, 1995.
46. Takehara T and Nakamura T: Protective effect of hepatocyte growth factor on in vitro hepatitis in primary cultured hepatocytes. Biomed Res 12: 335-338, 1991.
47. Mizuno S and Nakamura T: Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 166: 1895-1905, 2005.
48. Yamamoto K, Shimokawa T, Yi H, Isobe K, Kojima T, Loskutoff DJ and Saito H: Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am J Pathol 161: 1805-1814, 2002.
49. Mazzone M, Basilico C, Cavassa S, Pennacchietti S, Risio M, Naldini L, Comoglio PM and Michieli P: An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice. J Clin Invest 114: 1418-1432, 2004.
50. Itoh H, Naganuma S, Takeda N, Miyata S, Uchinokura S, Fukushima T, Uchiyama S, Tanaka H, Nagaike K, Shimomura T, Miyazawa K, Yamada G, Kitamura N, Koono M and Kataoka H: Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127: 1423-1435, 2004.